FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1

FDA Ombudsman Recommends Stakeholder Education

The FDA Office of Inspections and Investigations ombudsman program calls for establishing a dedicated Web page as a stakeholder education hub.

latest-news-card-1
Medical Devices

Orchestra BioMeds Trial OKd on Sirolimus Balloon

FDA approves an Orchestra BioMed IDE to begin a pivotal clinical trial evaluating its next generation Virtue Sirolimus-AngioInfusion Balloon for treat...

latest-news-card-1
Human Drugs

Fast Track Awarded to Polycythemia Vera Drug

FDA grants Italfarmaco a fast track designation to givinostat for treating patients with polycythemia vera, a rare hematologic cancer.

latest-news-card-1

FDA Implementing AI-Assisted Scientific Review

FDA commissioner Michael Makary says the agency is rolling out a generative AI-assisted scientific review tool to all Centers by 6/30.

Human Drugs

Court Confirms FDA Drug Shortage Ruling was Valid

A northern Texas judge rules in FDAs favor in a case challenging its decision last year to remove Eli Lillys weight loss and diabetes drugs Zepbound a...

Medical Devices

SS Innovations Seeks De Novo on Surgical Robot

SS Innovations says it will seek a de novo marketing authorization in July for its SSi Mantra 3 surgical robotic system.

latest-news-card-1
FDA General

Inspection Disruptions Wont Rise to Covid Level: Expert

Former CDER Office of Compliance director Don Ashley says inspection disruptions caused by recent FDA reductions in force will not rise to the level o...

Animal Drugs

Therivas Pancreatic Cancer Drug Hits Endpoints

Theriva Biologics reports positive Phase 2b VIRAGE topline results for its VCN-01 when added to standard of care chemotherapy to treat a form of pancr...

Biologics

Moderna Flu/Covid Vaccine Beats Comparators: Study

A Moderna Phase 3 study says its combination mRNA flu and Covid-19 vaccine achieved a greater immune response than comparator standard of care vaccine...

Human Drugs

Omeros BLA Resubmission for Narsoplimab

FDA accepts for review an Omeros BLA resubmission for narsoplimab for treating hematopoietic stem cell transplant-associated thrombotic microangiopath...